RSSSNasdaqServices-Business Services, NECUS GAAP · USD

Research Solutions, Inc.

Research Solutions, Inc. provides cloud-based research intelligence software and transactional content-delivery services for scientific and technical information. The company serves customers through its Article Galaxy platform and related tools, helping users discover, manage, and obtain scholarly articles and other STM content.

Kysy yhtiöstä
Liikevaihto48,3milj. USD
−1,5 %v/v
Liikevoitto (EBIT)3,6milj. USD
+43,5 %v/v
EBIT-marginaali7,4%
+2,3 %-yks.v/v
Nettotulos2,8milj. USD
+123,0 %v/v
Vapaa kassavirta5,2milj. USD
−25,3 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−200204060milj. USD2021: 32 milj. USD2021: EBIT −0,28 milj. USD20212022: 33 milj. USD2022: EBIT −1,6 milj. USD20222023: 38 milj. USD2023: EBIT 0,24 milj. USD20232024: 45 milj. USD2024: EBIT −0,77 milj. USD20242025: 49 milj. USD2025: EBIT 2,5 milj. USD20252026: 48 milj. USD2026: EBIT 3,6 milj. USD2026483,6
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Platforms43 %

Subscription access to cloud-based research intelligence and workflow software, including premium platform features.

Transactions57 %

Transactional delivery of STM articles and related copyright/service fees charged per order.

Tuotteet

Raportoitu · osuus liikevaihdosta
56,9%43,1%FY2026100 %
  • Transactions56,9 %
  • Platforms43,1 %

Lähde: 10-K FY2026, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

Customers include life science companies, academic institutions, and other research-intensive organizations that need fast access to scholarly and technical content. The company also sells to corporate libraries and non-library buyers in R&D and other business functions, especially in pharmaceutical, biotechnology, and medical device markets. Customers buy the service to reduce internal workflow burden, improve access to licensed content, and simplify copyright-compliant article delivery.

Life science companies

Pharmaceutical, biotechnology, and medical device customers use the platform for research content access, workflow efficiency, and collaboration.

Academic institutions

Universities and research libraries buy article delivery and content access services for faculty and researchers.

Corporate libraries

Enterprise library teams use the platform to manage subscriptions, authentication, and compliant content reuse.

R&D and non-library buyers

Scientists and business-function users buy direct access to articles and AI-enabled research tools.

Other research-intensive organizations

Aerospace, automotive, electronics, chemicals, and food/agriculture customers use the service for technical research.

Strategia

The company’s strategy centers on expanding its research workflow platform, cross-selling software into existing customers, and adding new interactive and AI-enabled tools. It also targets growth through direct sales, channel relationships, RFP-driven enterprise wins, and broader penetration of underserved small and medium-sized businesses. Product development and acquisitions are used to broaden the service portfolio and deepen customer value.

Cross-sell AI and platform productsLyhyt aikaväli

Raises value per customer and deepens workflow integration.

Expand into new customer verticalsKeskipitkä aikaväli

Diversifies demand beyond core life sciences and libraries.

Strengthen channel and direct sales reachLyhyt aikaväli

Improves customer acquisition efficiency and market coverage.

Broaden product functionality with AIKeskipitkä aikaväli

Keeps the platform relevant in research workflow software.

Maantiede

Q1/2026

Research Solutions is based in the United States and serves customers globally through its digital platform and publisher network. The business depends on access to content publishers and research customers across multiple end markets, with demand tied more to research activity than to any single country. Its service model is internet-based, so geography matters mainly through customer location, publisher relationships, and compliance requirements.

USA62 %
Europe38 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

The business depends on reliable software, secure data handling, and continued access to publisher content, so cybersecurity, privacy, and compliance failures could disrupt service and damage trust. It also faces competition from in-house customer solutions, publisher-owned tools, reference management apps, and piracy, which can pressure demand for paid content delivery. AI adoption adds both opportunity and risk because it can expose confidential information, create new security issues, and intensify competition.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Cybersecurity and IT system disruption1GenAI-related confidentiality and compliance exposure2Piracy and copyright non-compliance3Competition from publisher and reference tools4Customer in-house substitution5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Cybersecurity and IT system disruptionVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The platform depends on reliable networks and secure access to customer and publisher data.

    KohdistuuCustomer dataService availabilityReputation
  2. GenAI-related confidentiality and compliance exposureVaikutus: KorkeaTodennäköisyys: Kohtalainen

    AI tools may process sensitive customer or proprietary information and create new security risks.

    KohdistuuTrade secretsPersonal dataLegal compliance
  3. Piracy and copyright non-complianceVaikutus: KorkeaTodennäköisyys: Matala

    Unauthorized use of STM content can bypass paid transactional delivery and copyright fees.

    Kohdistuu: Transactions revenue

  4. Competition from publisher and reference toolsVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Alternative tools can reduce the need for third-party aggregation and workflow software.

    Kohdistuu: Market share and pricing

  5. Customer in-house substitutionVaikutus: KeskitasoTodennäköisyys: Matala

    Some customers can build or retain internal article delivery and workflow capabilities.

    Kohdistuu: Platform and transaction demand

Kirjanpito

Harkinnanvaraiset erät
ASC 606 revenue recognition

Platform subscriptions and transactional delivery are recognized differently, affecting timing of revenue.

Vaikutus: Revenue timing, deferred revenue, quarterly comparability

Deferred revenue

Advance billings for subscriptions create a liability until services are delivered.

Vaikutus: Working capital and revenue smoothing

Contingent earn-out liability

Acquisition-related earn-out estimates are remeasured using valuation assumptions.

Vaikutus: Earnings volatility and balance-sheet fair value changes

Goodwill impairment

Acquisitions create goodwill that must be tested for impairment annually or upon triggering events.

Vaikutus: Potential non-cash write-downs

Finite-lived intangible assets

Acquired software and customer-related intangibles may require impairment assessment.

Vaikutus: Amortization and possible impairment charges

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

FactSet Research Systems Inc

FDS · Services-Computer Programming, Data Processing, Etc.

UL Solutions Inc.

ULS · Services-Testing Laboratories

Penguin Solutions, Inc.

PENG · Semiconductors & Related Devices

Clarivate Plc

CLVT · Services-Computer Processing & Data Preparation

Artificial Intelligence Technology Solutions Inc.

AITX · Services-Prepackaged Software

Recursion Pharmaceuticals, Inc

RXRX · Biological Products, (No Diagnostic Substances)

Päivitetty: 24.9.2026

Research Solutions, Inc. (RSSS) liikevaihto, tulos ja tunnusluvut 2026 – Clarifo